Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.
Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, Engstrøm T, Matsumura M, Crowley A, Dressler O, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Okkels Jensen L, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Muller JE, Stone GW; PROSPECT II Investigators. Erlinge D, et al. Among authors: okkels jensen l. Lancet. 2021 Mar 13;397(10278):985-995. doi: 10.1016/S0140-6736(21)00249-X. Lancet. 2021. PMID: 33714389
Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
Hougaard M, Thayssen P, Kaltoft A, Tilsted HH, Maeng M, Lassen JF, Thuesen L, Okkels Jensen L. Hougaard M, et al. Among authors: okkels jensen l. Catheter Cardiovasc Interv. 2014 Jun 1;83(7):1035-42. doi: 10.1002/ccd.25279. Epub 2013 Dec 5. Catheter Cardiovasc Interv. 2014. PMID: 24311384 Clinical Trial.
Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-Segment Elevation Myocardial Infarction: Rationale, Design, and Methodology of the HONEST Study.
Fallesen CO, Maehara A, Antonsen L, Nørregaard Hansen K, Noori M, Flensted Lassen J, Junker A, Hansen HS, Okkels Jensen L. Fallesen CO, et al. Among authors: okkels jensen l. Cardiology. 2021;146(2):161-171. doi: 10.1159/000512417. Epub 2021 Feb 1. Cardiology. 2021. PMID: 33524985
Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study.
Pareek M, Madsen M, Warnakula Olesen KK, Okkels Jensen L, Høj Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker HE, Maeng M. Pareek M, et al. Among authors: okkels jensen l. EuroIntervention. 2019 Dec 6;15(11):e1022-e1024. doi: 10.4244/EIJ-D-19-00503. EuroIntervention. 2019. PMID: 31422923 Free article. No abstract available.
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial.
Sabaté M, Okkels Jensen L, Tilsted HH, Moreno R, García Del Blanco B, Macaya C, Pérez de Prado A, Cequier À, Pérez-Fuentes P, Schütte D, Costa RA, Stoll HP, Flensted Lassen J. Sabaté M, et al. Among authors: okkels jensen l. EuroIntervention. 2021 Jun 25;17(3):233-239. doi: 10.4244/EIJ-D-20-01162. EuroIntervention. 2021. PMID: 33433389 Free PMC article. Clinical Trial.
25 results